Post-discharge bleeding after ACS was associated with a significantly higher risk of subsequent all-cause mortality within 30 days (HR 15.7; 95% CI 12.3-20.0) and from 30 days to 12 months (HR 2.7).
Cohort (n=45,011)
Yes
Is post-discharge bleeding associated with increased subsequent all-cause mortality in patients with acute coronary syndrome treated with or without PCI?
Post-discharge bleeding after ACS carries a similar prognostic impact on mortality as post-discharge MI, regardless of whether the patient was initially treated with PCI.
Hazard Ratio: 15.7 (95% CI 12.3–20)
BACKGROUND The long-term prognostic impact of post-discharge bleeding in the unique population of patients with acute coronary syndrome (ACS) treated without percutaneous coronary intervention (PCI) remains unexplored. OBJECTIVES The aim of this study was to assess the association between post-discharge bleeding and subsequent mortality after ACS according to index strategy (PCI or no PCI) and to contrast with the association between post-discharge myocardial infarction (MI) and subsequent mortality. METHODS In a harmonized dataset of 4 multicenter randomized trials (APPRAISE-2 Apixaban for Prevention of Acute Ischemic Events-2, PLATO Study of Platelet Inhibition and Patient Outcomes, TRACER Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome, and TRILOGY ACS Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes), the association between post-discharge noncoronary artery bypass graft-related GUSTO (Global Use of Strategies to Open Occluded Coronary Arteries) moderate, severe, or life-threatening bleeding (landmark 7 days post-ACS) and subsequent all-cause mortality was evaluated in a time-updated Cox proportional hazards analysis. Interaction with index treatment strategy was assessed. Results were contrasted with risk for mortality following post-discharge MI. RESULTS Among 45,011 participants, 1,133 experienced post-discharge bleeding events (2.6 per 100 patient-years), and 2,149 died during follow-up. The risk for mortality was significantly higher <30 days (adjusted hazard ratio: 15.7; 95% confidence interval: 12.3 to 20.0) and 30 days to 12 months (adjusted hazard ratio: 2.7; 95% confidence interval: 2.1 to 3.4) after bleeding, and this association was consistent in participants treated with or without PCI for their index ACS (p for interaction = 0.240). The time-related association between post-discharge bleeding and mortality was similar to the association between MI and subsequent mortality in participants treated with and without PCI (p for interaction = 0.696). CONCLUSIONS Post-discharge bleeding after ACS is associated with a similar increase in subsequent all-cause mortality in participants treated with or without PCI and has an equivalent prognostic impact as post-discharge MI.
Marquis‐Gravel et al. (Wed,) conducted a cohort in Acute coronary syndrome (n=45,011). Post-discharge bleeding vs. No post-discharge bleeding was evaluated on Subsequent all-cause mortality <30 days after bleeding (HR 15.7, 95% CI 12.3-20.0). Post-discharge bleeding after ACS was associated with a significantly higher risk of subsequent all-cause mortality within 30 days (HR 15.7; 95% CI 12.3-20.0) and from 30 days to 12 months (HR 2.7).